JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v7i2.4777ArticleStudy on the Correlation Between SFRP-5 Expression Level, Insulin Resistance, and Glycolipid Metabolism in Gestational Diabetes Mellitushttps://artdesignp.com/journal/JCNR/7/2/10.26689/jcnr.v7i2.4777WangBei,CaoChenyuan,LiRui,AnYan,WangFang,HuangYuxiang,QinJinjin2023722023-03-30Objective: To investigate the correlation between serum secretory frizzled-related protein 5 (SFRP-5) expression levels and insulin resistance and glucolipid metabolism in patients with gestational diabetes mellitus (GDM). Methods: Baseline data were collected from 58 patients with GDM and 51 healthy controls who were admitted Affiliated Hospital of Hebei University from May 2020 to June 2022. sSTRA5 concentrations in peripheral blood of pregnant women were measured, and SFRP-5 levels in patients with different GDM types and normal controls were analyzed by logistic regression models. Results: The levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), fasting blood glucose (FBG), fasting insulin (FINS), hemoglobin A1c (HbA1c), and homeostasis model assessment-estimated insulin resistance (HOMA-IR) were higher in the observation group than in the control group, with statistically significant differences (P < 0.05), while the expression levels of high-density lipoprotein cholesterol (HDL-C) and serum SFRP-5 were lower than in the control group, with statistically significant differences (P < 0.05); serum SFRP-5, TG, TC, FBG, and HOMA-IR were all risk factors for GDM (P < 0.05). Conclusion: Elevated serum sSTRA5 may be involved in the regulation of insulin resistance in the body and the regulation of blood glucose in the body by affecting lipid metabolism and inflammatory response.

Yang G, Zheng D, Yang G, et al., 2022, Relationship Between Secretion of Crimp-Associated Protein 5 and Abnormal Glucose Metabolism in Patients with Gestational Diabetes Mellitus. Tianjin Pharmaceutical, 50(11): 1182–1186.

Zhang Q, Ying G, 2022, Relationship Between Serum Adipokine C1q Tumor Necrosis Factor-Associated Protein 3 and Retinin-1 Levels and Insulin Resistance in Gestational Diabetes Mellitus. China’s Maternity and Child Care, 5(22): 4165–4168.

He Y, Zhang Y, Fu A, et al., 2022, Expression of Serum Neutrophil Gelatinase-Related Lipid Carrier Protein in Patients with Gestational Diabetes Mellitus. China’s Family Planning, 30(5): 1115–1118.

Dai S, Rong K, Xu Y, et al., 2022, Relationship Between Serum Secreted Crimp-Associated Protein 5 and Insulin Resistance and Dietary Anti-Inflammatory Index in Gestational Diabetes Mellitus. China Maternal and Child Health Care, 37(07): 1217–1219.

Zhuang T, 2022, The Predictive Value of Glycosylated Albumin in the Diagnosis of Gestational Diabetes Mellitus and its Correlation with Pregnancy Outcome in Patients with Hyperglycemia During Pregnancy, dissertation, China Medical University.

Li S, He J, Xu Y, 2022, Diagnostic Value of Serum PGRN, CTRP3 and SFP-5 on Renal Injury in Patients with Gestational Diabetes Mellitus. Clinical Laboratory Medicine, 12(02): 196–199.

Wei M, Tang Q, Zhao L, et al., 2021, Relationship Between Serum Levels of Sex Hormone Binding Globulin, C1q/ Tumor Necrosis Factor-Associated Protein 6 and Insulin Resistance, Glucose and Lipid Metabolism in Patients with Gestational Diabetes Mellitus. Journal of Clinical Internal Medicine, 38(08): 534–536.

Cui L, 2021, Correlation Between Insulin Resistance and Serum Cytokines in Patients with Gestational Diabetes Mellitus. Medical BBS Magazine, 2021(15): 57–60 + 64.

Chuai F, Guo Y, 2021, The Nature Conservancy Council: Relationship Between Serum Placental Protein-13 and Secretory Crimp-Associated Protein 5 and Pregnancy Outcome in Patients with Gestational Diabetes Mellitus. Chinese Journal of Medical Frontier (Electronic), 13(6): 97–102.

Tan J, Li R, Guo Q, et al., 2021, Relationship Between Serum and Placental Oxidative Stress Related Proteins and Pregnancy Outcome in Patients with Gestational Diabetes Mellitus. Journal of Molecular Diagnostics and Therapeutics, 13(04): 631–634.

Ju W, Liu L, 2021, Expression of C1q/ Tumor Necrosis Factor-Associated Protein 9 Adipocyte Fatty Acid Binding Protein in Serum of Gestational Diabetes Mellitus and its Clinical Significance. China’s Maternity and Child Care, 4(02): 393–396.

Guo Z, Yao Y, Yao K, et al., 2019, Study on the Relationship Between Adipocytokines and TLR4/Myd88 Signaling Pathway in Gestational Diabetes Mellitus and its Clinical Significance. Chinese Journal of Immunology, 35(23): 2908–2910.

Wang Y, Yin X, Huo Y, et al., 2019, Expression and Significance of Neutrophil Gelatinase-Related Lipid Carrier Protein in Patients with Gestational Diabetes Mellitus. Advances in Obstetrics and Gynecology, 28(05): 325–328.

Chen F, Sun D, Yang H, et al., 2019, Expression of Secreted Frizzled-Related Protein 5 in Fat of Patients with Gestational Diabetes Mellitus and its Correlation with Insulin Resistance. Journal of Clinical and Experimental Medicine, 18(6): 623–626.

Li J, Wu G, Zong F, 2018, Analysis of Serum Complement C1q/TNF-1 Levels and Insulin Resistance-Related Factors in 60 Patients with Gestational Diabetes Mellitus. Maternal and Infant World, 2018(7): 29 + 32.